Shay Capital »

Acelrx Pharmaceuticals shares owned by Shay Capital

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Shay Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $187k 250k 0.75

More positions owned by Shay Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ftai Aviation SHS (FTAI)
Purecycle Technologies (PCT)
Meta Platforms Cl A (META)
Micron Technology (MU)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Russell 2000 Etf (IWM)
Thermo Fisher Scientific (TMO)
Papa John's Int'l (PZZA)
Celsius Hldgs Com New (CELH)
Intel Corporation (INTC)
Golar Lng SHS (GLNG)
Core Scientific (CORZ)
Amazon (AMZN)

View all positions for Shay Capital

Top funds holding Acelrx Pharmaceuticals

AIGH Capital Management
Rock Springs Capital Management
Rosalind Advisors
Nantahala Capital Management
Cantor Fitzgerald, L. P.
Bleichroeder
Caption Management
Vanguard Group
Empery Asset Management
Dauntless Investment Group
Almitas Capital
Vanguard Capital Management
Geode Capital Management
Susquehanna International
Renaissance Technologies

View all funds holding Acelrx Pharmaceuticals